Sophia Genetics SA (SOPH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Raised ... [Yahoo! Finance]
SOPHiA GENETICS SA - Ordinary Shares (SOPH)
Company Research
Source: Yahoo! Finance
2025 Revenue Guidance: Raised to $75 million to $77 million. US Revenue Growth: 30% year-over-year increase in Q3. Gross Margin: 73.1% on an adjusted basis in Q3. Adjusted EBITDA Improvement: 13% year-over-year improvement, excluding Swiss social charges. Operating Expenses: $30.8 million in Q3, affected by Swiss social charges and foreign exchange movements. Cash and Cash Equivalents: $81.6 million as of September 30. Platform Analysis Volume: Approximately 99,000 in Q3, up 9% year-over-year. Net Dollar Retention: 108% in Q3. Core Genomic Customers: 488 as of September 30. Adjusted EBITDA Loss Guidance: Revised to a loss of $39 million to $41 million for 2025. Warning! GuruFocus has detected 3 Warning Signs with SOPH. Is SOPH fairly valued? Test your thesis with our free DCF calculator. Release Date: November 04, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points Sophia Genetics SA (
Show less
Read more
Impact Snapshot
Event Time:
SOPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SOPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SOPH alerts
High impacting SOPHiA GENETICS SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
SOPH
News
- Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025 [Yahoo! Finance]Yahoo! Finance
- Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025PR Newswire
- SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision MedicinePR Newswire
- SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision Medicine [Yahoo! Finance]Yahoo! Finance
- SOPHiA GENETICS and Element Biosciences Unite Sequencing Power and AI Analytics to Accelerate Global Research In Precision MedicinePR Newswire
SOPH
Earnings
- 5/6/25 - Miss
SOPH
Analyst Actions
- 11/10/25 - BTIG
SOPH
Sec Filings
- 11/10/25 - Form 144
- 11/4/25 - Form 6-K
- 11/3/25 - Form 144
- SOPH's page on the SEC website